OnKure Therapeutics OKUR
NASDAQ OKUR
$2.54 -0.04 (-1.55%)
As of: Oct 23, 2026 · 2:12 PM EDT

OnKure Therapeutics (OKUR) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

OnKure Therapeutics (OKUR) posted Return on Capital Employed [ROCE] of -34.07% for Q2 2026, up 40.34 percentage points from -74.42% a year earlier and up 18.97 percentage points from the prior quarter.

Analysis

OnKure Therapeutics (OKUR) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, OnKure Therapeutics' Return on Capital Employed [ROCE] came in at -76.22%, up 7.72 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of -35.76 percentage points (FY2021 to FY2025).
  • In prior years, OnKure Therapeutics' Return on Capital Employed [ROCE] was -83.94% in FY2024 (-26.83 pp), -57.11% in FY2023 (-13.68 pp), -43.43% in FY2022 (-2.98 pp) and -40.46% in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -11.48 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2026, with a gain of 40.34 percentage points; the weakest was Q3 2025, with a drop of 72.79 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -53.04% (Q1 2026), -102.27% (Q4 2025) and -92.24% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,126.20 Bn 1,094.78 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 633.36 Bn 553.22 Bn 17.30 Bn 17.52%
3 AbbVie 504.51 Bn 477.62 Bn 12.70 Bn 17.92%
4 Merck 357.58 Bn 311.96 Bn 12.21 Bn 6.28%
5 Novartis Ag 289.65 Bn 253.64 Bn 11.24 Bn 19.32%
6 Astrazeneca 264.97 Bn 238.66 Bn 12.86 Bn 16.76%
7 Amgen 237.69 Bn 193.09 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.48 Bn 168.68 Bn 6.22 Bn -5.97%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 11.86%
10 OnKure Therapeutics 126.17 Mn -371.75 Mn - -34.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34.07%
Mar 31, 2026 -53.04%
Dec 31, 2025 -102.27%
Sep 30, 2025 -92.24%
Jun 30, 2025 -74.42%
Mar 31, 2025 -62.42%
Dec 31, 2024 -63.43%
Sep 30, 2024 -19.45%
Jun 30, 2024 -29.81%
Mar 31, 2024 -53.41%
Dec 31, 2023 -48.74%
Sep 30, 2023 -57.79%
Jun 30, 2023 -59.76%
Mar 31, 2023 -61.21%
Dec 31, 2022 -49.76%
Sep 30, 2022 -42.08%
Jun 30, 2022 -37.36%
Mar 31, 2022 -32.28%
Dec 31, 2021 -26.15%
Sep 30, 2021 -22.05%
API Access

OnKure Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OKUR&period=max&api_key=YOUR_API_KEY